Kirby John J. 4
4 · IDERA PHARMACEUTICALS, INC. · Filed Jan 6, 2021
Insider Transaction Report
Form 4
Kirby John J.
V.P. of Finance, PFO & PAO
Transactions
- Sale
Common Stock
2021-01-05$3.90/sh−862$3,362→ 35,575 total
Footnotes (2)
- [F1]Represents the number of shares of Issuer common stock required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of 2,563 Restricted Stock Units ("RSUs") on January 3, 2021. This sale is mandated by the Issuer's election under its 2013 Stock Incentive Plan to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.
- [F2]Of the reported securities beneficially owned, 25,125 shares are represented by unvested RSUs.